TABLE 2.
Subgroups | No. of studies | ES | LCI | UCI | I2 | P‐value | Subgroup difference |
---|---|---|---|---|---|---|---|
Method of measurement | |||||||
ELISA | 7 | −1.159 | −1.977 | −0.341 | 95.70% | 0.005 | 0.055 |
Luminex | 2 | −0.105 | −0.383 | 0.174 | 11.46% | 0.461 | |
Others | 3 | −0.303 | −0.792 | 0.186 | 66.15% | 0.224 | |
Country of study | |||||||
China | 4 | −0.718 | −2.218 | 0.692 | 97.45% | <0.001 | 0.089 |
Italy | 2 | 0.073 | −0.154 | 0.299 | 0% | 0.997 | |
USA | 2 | −0.369 | −0.782 | 0.044 | 48.91% | 0.162 | |
Others | 4 | 0.361 | −0.13 | 0.852 | 65.14% | 0.035 | |
Sex ratio | |||||||
<50% | 2 | −0.548 | −0.965 | −0.13 | 0.00% | 0.01 | 0.555 |
>50% | 9 | −0.804 | −1.398 | −0.21 | 95.08% | 0.008 | |
Disease duration | |||||||
≤7 years | 4 | −0.941 | −1.807 | −0.074 | 91.54% | 0.033 | 0.028 |
>7 years | 3 | 0.005 | −0.426 | 0.436 | 68.12% | 0.982 |